- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 233/96 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
Patent holdings for IPC class C07D 233/96
Total number of patents in this class: 118
10-year publication summary
|
8
|
2
|
8
|
3
|
10
|
12
|
6
|
6
|
14
|
6
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Siemens Medical Solutions USA, Inc. | 1502 |
7 |
| TES Pharma S.r.l. | 20 |
6 |
| Hydro-Quebec | 656 |
4 |
| King Abdulaziz University | 512 |
4 |
| Murata Manufacturing Co., Ltd. | 24928 |
3 |
| King Faisal University | 921 |
3 |
| F. Hoffmann-La Roche AG | 7932 |
2 |
| Merck Sharp & Dohme Corp. | 2190 |
2 |
| Bayer Cropscience AG | 1997 |
2 |
| Celon Pharma S.A. | 37 |
2 |
| Constellation Pharmaceuticals, Inc. | 211 |
2 |
| Duksung Women's University Industry-academic Cooperation Foundation | 9 |
2 |
| Kyulux, Inc. | 237 |
2 |
| Rohto Pharmaceutical Co., Ltd. | 388 |
2 |
| Universitetet I Tromso - Norges Arktiske Universitet | 68 |
2 |
| Uniwersytet Jagiellonski | 265 |
2 |
| Insilico Medicine IP Limited | 106 |
2 |
| Nodthera Limited | 40 |
2 |
| Axonis Therapeutics, Inc. | 10 |
2 |
| Fluorescence Diagnosis (Shanghai) Biotech Company Ltd. | 7 |
2 |
| Other owners | 63 |